These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21986812)

  • 1. Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells.
    Suzuki O; Hirsch B; Abe M; Dürkop H; Stein H
    Lab Invest; 2012 Feb; 92(2):191-9. PubMed ID: 21986812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
    Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
    J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
    Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
    Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin.
    Chen R; Hou J; Newman E; Kim Y; Donohue C; Liu X; Thomas SH; Forman SJ; Kane SE
    Mol Cancer Ther; 2015 Jun; 14(6):1376-84. PubMed ID: 25840583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells.
    Wright CW; Rumble JM; Duckett CS
    J Biol Chem; 2007 Apr; 282(14):10252-62. PubMed ID: 17261581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma.
    Watanabe M; Ogawa Y; Itoh K; Koiwa T; Kadin ME; Watanabe T; Okayasu I; Higashihara M; Horie R
    Lab Invest; 2008 Jan; 88(1):48-57. PubMed ID: 17965727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
    Staber PB; Noehammer C; Dürkop H; Schauer S; Kenner L; Linkesch W; Hoefler G
    Leuk Res; 2006 Mar; 30(3):343-8. PubMed ID: 16198418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
    Parekh P; Kamble S; Zhao N; Zeng Z; Portier BP; Zu Y
    Biomaterials; 2013 Nov; 34(35):8909-17. PubMed ID: 23968853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30-induced up-regulation of the inhibitor of apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cells.
    Hübinger G; Schneider C; Stöhr D; Ruff H; Kirchner D; Schwänen C; Schmid M; Bergmann L; Müller E
    Exp Hematol; 2004 Apr; 32(4):382-9. PubMed ID: 15050749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma.
    Watanabe M; Itoh K; Togano T; Kadin ME; Watanabe T; Higashihara M; Horie R
    Am J Pathol; 2012 Feb; 180(2):831-8. PubMed ID: 22107829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
    Hsu PL; Hsu SM
    Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
    Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF
    Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells.
    Mir SS; Richter BW; Duckett CS
    Blood; 2000 Dec; 96(13):4307-12. PubMed ID: 11110706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3.
    Nishikori M; Ohno H; Haga H; Uchiyama T
    Cancer Sci; 2005 Aug; 96(8):487-97. PubMed ID: 16108830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIP1 expression is necessary for CD30-mediated cell death induction in anaplastic large-cell lymphoma cells.
    Hirsch B; von der Wall E; Hummel M; Dürkop H
    Lab Invest; 2013 Jun; 93(6):677-89. PubMed ID: 23545938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells].
    Hirsch B; Braun FK; Al-Yacoub N; Assaf C; Kadin ME; Sterry W; Eberle J; Dürkop H
    Pathologe; 2010 Oct; 31 Suppl 2():193-8. PubMed ID: 20812013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
    Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
    Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells.
    Krysov SV; Rowley TF; Al-Shamkhani A
    Mol Cancer Ther; 2007 Feb; 6(2):703-11. PubMed ID: 17308066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
    Nakashima M; Uchimaru K
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma.
    Horie R; Watanabe M; Ishida T; Koiwa T; Aizawa S; Itoh K; Higashihara M; Kadin ME; Watanabe T
    Cancer Cell; 2004 Apr; 5(4):353-64. PubMed ID: 15093542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.